Measuring the impact of targeted indoor spraying on diseases spread by Aedes mosquitoes
Quanitifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases
This study is looking at a new way to spray insecticides in specific areas to help control diseases like dengue and chikungunya caused by Aedes mosquitoes, and it aims to see if this method can help keep you and your community healthier.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10812992 on NIH RePORTER |
What this research studies
This research investigates how targeted indoor residual spraying (TIRS) can effectively control diseases spread by Aedes mosquitoes, such as dengue and chikungunya. By focusing on specific areas where these mosquitoes rest, the study aims to improve the efficacy of insecticide applications. The approach includes a randomized trial to gather data on the epidemiological effects of this method in urban settings. Patients may benefit from reduced incidence of these diseases as a result of improved vector control strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in urban areas where Aedes mosquitoes are prevalent, particularly those at risk for dengue and chikungunya.
Not a fit: Patients who do not reside in areas affected by Aedes-borne diseases or those who are not at risk for these infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention of Aedes-borne diseases, ultimately reducing illness and improving public health.
How similar studies have performed: Previous research has shown promise for targeted indoor residual spraying as an effective vector control method, although this specific approach is still being evaluated in randomized trials.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Vazquez Prokopec, Gonzalo Martin — Emory University
- Study coordinator: Vazquez Prokopec, Gonzalo Martin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.